Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Traveling Alone: An Excursion of Self-Disclosure - 2Fundamental Home Machines: An Easy to understand Determination Guide
- 3How to watch 2026 Golden Globe winners like 'One Battle After Another,' 'Adolescence' and 'The Pitt'
- 46 Natural products High In Vitamins,Which One Do You Like to Eat
- 5Firefighters rescue two Israelis trapped in vehicles on flooded roads in West Bank
- Eleven Creations And Developments That Steered History
- Investigate Business Mastercard Choices for Better Rewards and Rewards
- Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
- 5 Signs Now is the ideal time to Update Your Android Telephone: When to Take the Action
- We may be witnessing the messy death of a star in real time
- Giude to Best Web based Learning Stage
- Figure out How to Streamline Eco-friendliness in Your Volvo XC40
- JFK's granddaughter Tatiana Schlossberg reveals terminal cancer diagnosis
- Black Friday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
